Literature DB >> 17533377

A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation.

A Depaux1, F Regnier-Ricard, A Germani, N Varin-Blank.   

Abstract

Protein inhibitor of activated STAT (Pias) and human homologues of seven in absentia (hSiah) proteins both exhibit properties of ubiquitin-family peptides conjugating enzymes. Pias present E3-ligase activity for small ubiquitin-related modifiers (Sumo) covalent attachment to their targets. This post-translational modification is responsible for the activation of different transcription factors such as AP1. HSiah proteins possess ubiquitin-E3-ligase activity that triggers their partners to proteasomal-dependent degradation. The present study identifies Pias as a new hSiah2-interacting protein. We demonstrate that hSiah2 regulates specifically the proteasome-dependent degradation of Pias proteins. On reverse, Pias does not prevent hSiah2 degradation. We provide evidences for hSiah2-dependent degradation of Pias as being a mechanism in the regulation of c-jun N-terminal kinase-activating pathways. This report describes a new interconnection between sumoylation and ubiquitination pathways by regulating the levels of the E3-ligases available for these processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17533377     DOI: 10.1038/sj.onc.1210486

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

Review 1.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

Review 2.  Regulation of the sumoylation system in gene expression.

Authors:  Bin Liu; Ke Shuai
Journal:  Curr Opin Cell Biol       Date:  2008-05-28       Impact factor: 8.382

Review 3.  PIAS proteins: pleiotropic interactors associated with SUMO.

Authors:  Miia M Rytinki; Sanna Kaikkonen; Petri Pehkonen; Tiina Jääskeläinen; Jorma J Palvimo
Journal:  Cell Mol Life Sci       Date:  2009-06-13       Impact factor: 9.261

4.  The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion.

Authors:  Marzia Scortegagna; Annabel Berthon; Nikolaos Settas; Andreas Giannakou; Guillermina Garcia; Jian-Liang Li; Brian James; Robert C Liddington; José G Vilches-Moure; Constantine A Stratakis; Ze'ev A Ronai
Journal:  JCI Insight       Date:  2017-12-07

Review 5.  The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.

Authors:  Jaclyn R Gareau; Christopher D Lima
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12       Impact factor: 94.444

6.  SIAH-1 interacts with the Kaposi's sarcoma-associated herpesvirus-encoded ORF45 protein and promotes its ubiquitylation and proteasomal degradation.

Authors:  Rinat Abada; Tsofia Dreyfuss-Grossman; Yifat Herman-Bachinsky; Haim Geva; Shiri-Rivka Masa; Ronit Sarid
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

7.  B Cell Receptor Activation and Chemical Induction Trigger Caspase-Mediated Cleavage of PIAS1 to Facilitate Epstein-Barr Virus Reactivation.

Authors:  Kun Zhang; Dong-Wen Lv; Renfeng Li
Journal:  Cell Rep       Date:  2017-12-19       Impact factor: 9.423

Review 8.  Starting and stopping SUMOylation. What regulates the regulator?

Authors:  Felicity Z Watts
Journal:  Chromosoma       Date:  2013-06-28       Impact factor: 4.316

9.  PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells.

Authors:  W Chien; K L Lee; L W Ding; P Wuensche; H Kato; N B Doan; L Poellinger; J W Said; H P Koeffler
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

10.  Nitric oxide destabilizes Pias3 and regulates sumoylation.

Authors:  Jing Qu; Guang-Hui Liu; Kaiyuan Wu; Peiwei Han; Peng Wang; Jiangmei Li; Xu Zhang; Chang Chen
Journal:  PLoS One       Date:  2007-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.